Dirk de Naeyer appointed Chief Operations Officer and Martine Nolan as Head of Quality Assurance, effective March 1, 2019
Amsterdam, The Netherlands, March 5, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces senior management appointments to further strengthen the Company as it transitions into commercial stage. Dirk de Naeyer, who joined Kiadis Pharma in October 2018 as Head of Supply Chain, moves to the position of Chief Operations Officer, as a planned succession from Jan Feijen. Martine Nolan joins as Head of Quality Assurance. Both de Naeyer and Nolan will report to Kiadis' CEO Arthur Lahr and be members of the Company's management team.
Arthur Lahr, CEO of Kiadis Pharma, commented: "To start, I would like to thank Jan for his contributions to Kiadis. He has been instrumental in building the operations team with several talented individuals, including Dirk, who has already made a substantial contribution to our supply chain and development. Martine's track record in commercial quality and manufacturing, combined with Dirk's experience leading operations in both clinical and commercial-stage biotechnology companies, will contribute to our position as a leading fully-integrated biopharmaceutical company. I am delighted to welcome Dirk and Martine to their new positions - with their appointments, we have strengthened and completed our leadership team, adding new capabilities and expertise in anticipation of potential product commercialization and scale up."
Prior to joining Kiadis, Mr. de Naeyer was at Janssen Pharmaceuticals where he spent 14 years in various leadership positions. Most recently, he was R&D and Regulatory lead for the integration of Actelion into Janssen. Before that, he was the head of the Janssen Global Clinical Operations team and held supply chain and manufacturing leadership positions in both commercial and clinical-stage small molecules, biologics and stem cell platforms. Mr. de Naeyer joined Janssen after five years at McKinsey. He holds a Masters in Engineering from the KU Leuven, Belgium, and an MBA from the University of Chicago.
Ms. Nolan brings over 20 years of experience in the pharmaceutical sector to Kiadis which she joins from Amgen where she served as Regional Head of Quality Operations, leading a team of more than 200 employees at the Dublin, Ireland and Breda, Netherlands sites. Prior to that Ms. Nolan served as Executive Director for International Quality, Turkey, Middle East & Africa where she had responsibility for quality of both manufacturing and distribution activities. Before joining Amgen, Ms. Nolan held several positions of increasing responsibility in quality operations at Schering-Plough (Merck) in Ireland, Singapore and US. Ms. Nolan holds a MSc in Cellular Physiology from University College Cork and a BSc in Biochemistry from University College Dublin.